Back
Dermata Therapeutics 10K Form
Sell
17
DRMA
Dermata Therapeutics
Last Price:
1.95
Seasonality Move:
-51.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DRMA News And Ratings
See the #1 stock for the next 7 days that we like better than DRMA
DRMA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-2.13M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.79 |
| Price / Book: | 0.89 |
Profitability
| EPS (TTM): | -27.47320 |
|---|---|
| Net Income (TTM): | $-9.82M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Dermata Therapeutics Earnings Forecast
Key Dermata Therapeutics Financial Ratios
- The Interest Expense is 0.62% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Dermata Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DRMA |
| Website: | dermatarx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DRMA Technical Analysis vs Fundamental Analysis
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a Sell
The current Dermata Therapeutics [DRMA] share price is $2.25. The Score for DRMA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.